Compounds > fucose

fucose and kifunensine

fucose has been researched along with kifunensine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Aricescu, AR; Chang, VT; Crispin, M; Davis, SJ; Dwek, RA; Harvey, DJ; Jones, EY; Rudd, PM; Yu, C1
Culm-Merdek, K; Edmunds, T; Estes, S; McVie-Wylie, A; Pan, C; Park, A; Qiu, H; Roy, A; Shankara, S; Zhou, Q1
Barboza, M; Lebrilla, CB; Mills, DA; Park, D; Raybould, H; Shah, IM; Wong, M; Xu, G1
Carrillo, B; Deng, J; Holtz, B; Kommineni, V; Marcel, S; Markert, M; McDonald, KA; Nandi, S; Palle, S; Ren, Z; Tejeda, A1
Lam, M; Lebrilla, CB; Xie, Y; Zhou, Q1

Other Studies

5 other study(ies) available for fucose and kifunensine

ArticleYear
Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway.
    Glycobiology, 2006, Volume: 16, Issue:8

    Topics: 1-Deoxynojirimycin; Alkaloids; alpha-Mannosidase; Animals; Cell Line; CHO Cells; Cricetinae; DNA, Complementary; Enzyme Inhibitors; Fucose; Glycoproteins; Glycosylation; Humans; N-Acetylglucosaminyltransferases; Recombinant Proteins; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Swainsonine

2006
Development of a simple and rapid method for producing non-fucosylated oligomannose containing antibodies with increased effector function.
    Biotechnology and bioengineering, 2008, Feb-15, Volume: 99, Issue:3

    Topics: Alkaloids; Animals; Antibodies, Monoclonal; CHO Cells; Cricetinae; Cricetulus; Fucose; Gene Expression Regulation; Mannose; Mice; Protein Engineering

2008
Enterocyte glycosylation is responsive to changes in extracellular conditions: implications for membrane functions.
    Glycobiology, 2017, 09-01, Volume: 27, Issue:9

    Topics: Alkaloids; Caco-2 Cells; Carbohydrate Sequence; Cell Membrane; Enzyme Inhibitors; Fatty Acids, Volatile; Fructose; Fucose; Galactose; Glutamine; Glycomics; Glycosylation; HT29 Cells; Humans; Mannose; Mannosidases

2017
In Vivo Glycan Engineering via the Mannosidase I Inhibitor (Kifunensine) Improves Efficacy of Rituximab Manufactured in
    International journal of molecular sciences, 2019, Jan-07, Volume: 20, Issue:1

    Topics: Alkaloids; Antibody-Dependent Cell Cytotoxicity; Antigens, CD20; Fucose; Glycosylation; Mannose; Mannosidases; Metabolic Engineering; Nicotiana; Polysaccharides; Rituximab

2019
    Cells, 2021, 09-04, Volume: 10, Issue:9

    Topics: A549 Cells; Alkaloids; Caco-2 Cells; Chromatography, Liquid; Enzyme Inhibitors; Fucose; Glycocalyx; Glycomics; Glycoproteins; Glycosylation; Glycosyltransferases; Humans; Lab-On-A-Chip Devices; Mass Spectrometry; Microfluidic Analytical Techniques; Molecular Structure; Neuraminic Acids; Polysaccharides; Proteomics; Structure-Activity Relationship

2021